ArticleScientific reports2025
Ag/ZnO nanodots from Artemisia austroyunnanensis as antibacterial and anticancer agents against human neuroblastoma cells.
Article in Scientific reports, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed.
- Green synthesis of Ag-Fe₂O₃ nanocomposite using Adiantum venustum D. Don. extract and evaluation of its antimicrobial and antioxidant properties.Discover nano · 2026Article
- Green synthesis of ZnO nanoparticles from the leaves of Passiflora foetida L. and its antimicrobial and cytotoxic activities.Die Naturwissenschaften · 2026Article
- Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The green synthesis of multifunctional Ag/ZnO nanodots using Artemisia austroyunnanensis leaf extract was explored for their antibacterial, antioxidant, and anticancer properties. Characterization techniques confirmed the successful synthesis of nanodots with a nanoscale size (9.02 ± 1.58 nm), high crystallinity, and distinct ZnO and Ag phases. The synthesized nanodots exhibited significant antibacterial activity against Gram-positive and Gram-negative bacteria, with the largest zone of inhibition observed for Salmonella typhimurium (21 ± 1 mm at 300 µg/mL). Antioxidant assays demonstrated robust free radical scavenging activity, particularly in the ABTS assay (IC
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.